documents: FDA-2014-N-0002-0044
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2014-N-0002-0044 | FDA | FDA-2014-N-0002 | New Animal Drugs; Buprenorphine; Carprofen; Danofloxacin; Follicle Stimulating Hormone; Ractopamine; Salinomycin; Tylosin | Rule | Final Rule | 2014-09-08T04:00:00Z | 2014 | 9 | 2014-09-08T04:00:00Z | 2014-09-08T16:53:36Z | 2014-20325 | 0 | 0 | 09000064818632fd |
Links from other tables
- 1 row from regs_document_id in fr_regs_crossref